| Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer RB Birge, S Boeltz, S Kumar, J Carlson, J Wanderley, D Calianese, ... Cell Death and Differentiation 23, 962–978, 2016 | 607 | 2016 |
| Integrin αvβ6–TGFβ–SOX4 pathway drives immune evasion in triple-negative breast cancer A Bagati, S Kumar, P Jiang, J Pyrdol, AE Zou, A Godicelj, ND Mathewson, ... Cancer cell 39 (1), 54-67. e9, 2021 | 116 | 2021 |
| Phosphatidylserine Sensing by TAM Receptors Regulates AKT-dependent Chemoresistance and PD-L1 Expression C Kasikara, S Kumar, S Kimani, WI Tsou, K Geng, V Davra, G Sriram, ... Mol Cancer Res, 2017 | 112 | 2017 |
| Inhibition of MICA and MICB shedding elicits NK-cell–mediated immunity against tumors resistant to cytotoxic T cells L Ferrari de Andrade, S Kumar, AM Luoma, Y Ito, PH Alves da Silva, ... Cancer immunology research 8 (6), 769-780, 2020 | 85 | 2020 |
| Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment S Kumar, D Calianese, RB Birge Immunological reviews 280 (1), 149-164, 2017 | 81 | 2017 |
| Contribution of defective PS recognition and efferocytosis to chronic inflammation and autoimmunity SG Kimani, K Geng, C Kasikara, S Kumar, G Sriram, Y Wu, RB Birge Chronic inflammation in conditions associated with a deficient clearance of …, 2015 | 76 | 2015 |
| Requirement of gamma-carboxyglutamic acid modification and phosphatidylserine binding for the activation of Tyro3, Axl, and Mertk receptors by growth arrest-specific 6 K Geng, S Kumar, SG Kimani, V Kholodovych, C Kasikara, K Mizuno, ... Frontiers in immunology 8, 1521, 2017 | 68 | 2017 |
| CARM1 inhibition enables immunotherapy of resistant tumors by dual action on tumor cells and T cells S Kumar, Z Zeng, A Bagati, RE Tay, LA Sanz, SR Hartono, Y Ito, ... Cancer discovery 11 (8), 2050-2071, 2021 | 53 | 2021 |
| Axl and Mertk receptors cooperate to promote breast cancer progression by combined oncogenic signaling and evasion of host antitumor immunity V Davra, S Kumar, K Geng, D Calianese, D Mehta, V Gadiyar, C Kasikara, ... Cancer research 81 (3), 698-712, 2021 | 47 | 2021 |
| Epithelial IL-15 is a critical regulator of γδ intraepithelial lymphocyte motility within the intestinal mucosa MD Hu, AD Ethridge, R Lipstein, S Kumar, Y Wang, B Jabri, JR Turner, ... The Journal of Immunology 201 (2), 747-756, 2018 | 45 | 2018 |
| Crk adaptor protein promotes PD-L1 expression, EMT and immune evasion in a murine model of triple-negative breast cancer S Kumar, V Davra, AE Obr, TL Wood, RB Birge Oncoimmunology, 2017 | 43 | 2017 |
| Efferocytosis S Kumar, RB Birge Current Biology 26, R543–R576, 2016 | 41 | 2016 |
| Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity SG Kimani, S Kumar, N Bansal, K Singh, V Kholodovych, T Comollo, ... Scientific reports, 2017 | 40 | 2017 |
| Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment AE Obr, S Kumar, YJ Chang, JJ Bulatowicz, BJ Barnes, RB Birge, ... Breast Cancer Research 20, 1-17, 2018 | 37 | 2018 |
| FUSE Binding Protein1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53 U Dixit, A Pandey, Z Liu, S Kumar, M Neiditch, K Klein, V Pandey Journal of Virology, 2015 | 35 | 2015 |
| Crk at the Quarter Century Mark: Perspectives in Signaling and Cancer S Kumar, F Eduardo, RB Birge, S Ganapathy Journal of Cellular Biochemistry 115 (5), 819–825, 2014 | 32 | 2014 |
| Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase SG Kimani, S Kumar, V Davra, YJ Chang, C Kasikara, K Geng, WI Tsou, ... Cell Communication and Signaling 14 (1), 1-15, 2016 | 31 | 2016 |
| Crk tyrosine phosphorylation regulates PDGF-BB–inducible src activation and breast tumorigenicity and metastasis S Kumar, B Lu, V Davra, P Hornbeck, K Machida, RB Birge Molecular cancer research 16 (1), 173-183, 2018 | 26 | 2018 |
| Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma S Kumar, B Lu, U Dixit, S Hossain, Y Liu, J Li, P Hornbeck, W Zheng, ... Oncotarget 6 (35), 37792- 37807, 2015 | 26 | 2015 |
| Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity JC Melms, S Vallabhaneni, CE Mills, C Yapp, JY Chen, E Morelli, ... Cancer research 80 (4), 798-810, 2020 | 25 | 2020 |
Ke GengNew York University Langone Medical Center/Laura and Isaac Perlmutter Cancer CenterПодтвержден адрес электронной почты в домене nyulangone.org
